LIU O C, HENLE W
J Exp Med. 1953 Jun;97(6):889-902. doi: 10.1084/jem.97.6.889.
Equal mixtures of influenza A (PR8) and B (Lee) viruses, based on predetermined ID(50) values of the individual preparations, were titrated in closely spaced steps near the 50 per cent infectivity end-point. Typing of the hemagglutinins found in the allantoic fluids after incubation of the eggs for 72 hours showed an approximately equal distribution between types A and B, when less than 2 ID(50) of the mixed seed had been injected. With larger inocula influenza A became dominant because it reproduces at a faster rate than the influenza B virus. While this result agreed with expectations, it was found that passage of the allantoic fluids revealing influenza A agglutinins in mixture with anti-A serum, and of B agglutinins with anti-B, yielded the heterologous virus in many instances, even when only one-half of an ID(50) of mixed seed had been administered in the original titration. "Negative" fluids obtained from embryos injected with as little as one-eighth of an ID(50) upon passage yielded on occasion virus of one or the other type. Similar closely spaced titrations near the 50 per cent end-point of single strains (PR8) indicated that if hemagglutinins were found after incubation of 72 hours they were of high titer, as a rule. However, in some embryos hemagglutinins became detectable only between the 3rd and 4th days of incubation. In addition, negative allantoic fluids removed from embryos 72 hours after injection yielded on occasion virus on passage, yet no hemagglutinins were found in some of these eggs after an additional incubation period of 24 hours, or a total of 96 hours. None of the possible explanations for these various observations, which have been discussed in detail, is completely satisfactory. However, the data indicate that in infectivity titrations the ID(50) end-point obtained at 72 hours, or even after 96 hours, does not reflect the total amount of virus present in the material titrated. The data also denote that separation of variants, or mutants or "genetic recombinants" by the limiting dilution technic, although possible, does not represent an absolutely safe procedure.
根据各制剂预先确定的半数感染剂量(ID50)值,将甲型流感病毒(PR8株)和乙型流感病毒(Lee株)等比例混合,在接近50%感染终点处进行紧密间隔的滴定。在鸡胚孵化72小时后,对尿囊液中发现的血凝素进行分型,结果显示,当注射的混合种毒少于2个ID50时,甲型和乙型的分布大致相等。接种量较大时,甲型流感病毒占主导,因为其繁殖速度比乙型流感病毒快。虽然这一结果与预期相符,但发现尿囊液传代时,与抗A血清混合显示甲型流感血凝素,与抗B血清混合显示乙型流感血凝素,在许多情况下会产生异源病毒,即使在最初滴定中仅接种了半个ID50的混合种毒。从接种量低至八分之一个ID50的鸡胚中获得的“阴性”尿囊液传代时,偶尔会产生某一型别的病毒。在接近单株(PR8株)50%终点处进行的类似紧密间隔滴定表明,如果在72小时孵化后发现血凝素,通常其效价较高。然而,在一些鸡胚中,血凝素仅在孵化的第3天至第4天之间才可检测到。此外,注射72小时后从鸡胚中取出的阴性尿囊液传代时偶尔会产生病毒,但在额外孵育24小时(即总共96小时)后,其中一些鸡胚中未发现血凝素。对于这些已详细讨论的各种观察结果,没有一种可能的解释是完全令人满意的。然而,数据表明,在感染性滴定中,72小时甚至96小时获得的ID50终点并不反映被滴定材料中存在的病毒总量。数据还表明,通过有限稀释技术分离变异株、突变株或“基因重组体”虽然可行,但并非绝对安全的程序。